SCHEMBL31679381

CCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)[C@@H](C)CC)C(=O)N[C@@H](CCS)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	AGTR2	P50052	5/20	0.50

▸	AGTR1	P30556	4/20	0.50

▸	MAPK8	P45983	1/20	0.50

▸	MAPK9	P45984	1/20	0.50

▸	MAPK10	P53779	1/20	0.50

▸	OPRD1	P41143	4/20	0.50

▸	NTSR2	O95665	2/20	0.48

▸	NTSR1	P30989	2/20	0.48

▸	NMUR2	Q9GZQ4	4/20	0.48

▸	NMUR1	Q9HB89	4/20	0.48

▸	F2	P00734	1/20	0.48

▸	SORT1	Q99523	1/20	0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31679451	0.98	AGTR2 (0.52)	AGTR2AGTR1MAPK8MAPK9MAPK10
SCHEMBL31679423	0.97	AGTR2 (0.51)	AGTR2AGTR1MAPK8MAPK9MAPK10
SCHEMBL31679406	0.97	MAPK8 (0.51)	AGTR2AGTR1MAPK8MAPK9MAPK10
SCHEMBL31679462	0.96	AGTR2 (0.52)	AGTR2AGTR1MAPK8MAPK9MAPK10
SCHEMBL31679388	0.95	OPRD1 (0.50)	AGTR2AGTR1MAPK8MAPK9MAPK10
SCHEMBL31679422	0.95	AGTR2 (0.52)	AGTR2AGTR1OPRD1NTSR2NTSR1
SCHEMBL31679389	0.94	AGTR2 (0.50)	AGTR2AGTR1MAPK8MAPK9MAPK10
SCHEMBL31679341	0.93	AGTR2 (0.52)	AGTR2AGTR1OPRD1NTSR2NTSR1
SCHEMBL31679425	0.93	MAPK8 (0.48)	AGTR2AGTR1MAPK8MAPK9MAPK10
SCHEMBL31679411	0.93	NTSR1 (0.53)	MAPK8MAPK9MAPK10NTSR2NTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4610269-A1	UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE	3B Pharmaceuticals GmbH (DE)	2025-09-03	—	—	EP	disclosed